Global Oral GLP-1 Market Size, Share, Growth & Industry Analysis By Drug Class (GLP-1 Receptor Agonist Monotherapy, Dual GLP-1/GIP Receptor Agonists, Triple Agonists – GLP-1/GIP/Glucagon), By Therapeutic Indication (Type 2 Diabetes, Obesity & Weight Management, Cardiovascular Risk Reduction, Others), By Formulation Type (Peptide-Based Oral Formulations, Small Molecule GLP-1 Agonists), By Distribution Channel (Retail, Specialty, Hospital Pharmacies, Telehealth) Industry Trends & Forecast 2026–2034